Financial Partners Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $13M | Buy |
254,633
+459
| +0.2% | +$22K | 2.9% | 9 |
|
|
2022
Q3 | $11.1M | Buy |
254,174
+199
| +0.1% | +$9.67K | 2.63% | 9 |
|
|
2022
Q2 | $13.3M | Buy |
253,975
+879
| +0.3% | +$44.8K | 2.86% | 8 |
|
|
2022
Q1 | $13.1M | Buy |
253,096
+727
| +0.3% | +$37.7K | 2.43% | 14 |
|
|
2021
Q4 | $14.9M | Buy |
252,369
+1,351
| +0.5% | +$66.9K | 2.64% | 10 |
|
|
2021
Q3 | $10.8M | Buy |
251,018
+11,105
| +5% | +$492K | 1.97% | 19 |
|
|
2021
Q2 | $9.4M | Buy |
239,913
+20,492
| +9% | +$797K | 1.72% | 23 |
|
|
2021
Q1 | $7.95M | Buy |
219,421
+182,535
| +495% | +$6.48M | 1.61% | 24 |
|
|
2020
Q4 | $1.36M | Buy |
36,886
+17,527
| +91% | +$643K | 0.31% | 52 |
|
|
2020
Q3 | $674K | Hold |
19,359
| – | – | 0.18% | 62 |
|
|
2020
Q2 | $601K | Sell |
19,359
-132
| -0.7% | -$4.48K | 0.17% | 61 |
|
|
2020
Q1 | $604K | Buy |
+19,491
| New | +$664K | 0.19% | 60 |
|
|
2018
Q4 | $2.43M | Sell |
58,710
-168,717
| -74% | -$7M | 0.8% | 36 |
|
|
2018
Q3 | $9.51M | Sell |
227,427
-63,578
| -22% | -$2.45M | 2.7% | 18 |
|
|
2018
Q2 | $10M | Sell |
291,005
-2,962
| -1% | -$101K | 3.04% | 12 |
|
|
2018
Q1 | $9.9M | Sell |
293,967
-1,724
| -0.6% | -$59.3K | 2.98% | 12 |
|
|
2017
Q4 | $10.2M | Sell |
295,691
-4,165
| -1% | -$142K | 1.88% | 19 |
|
|
2017
Q3 | $10.2M | Buy |
299,856
+1,422
| +0.5% | +$45.7K | 1.94% | 15 |
|
|
2017
Q2 | $9.51M | Sell |
298,434
-3,213
| -1% | -$101K | 1.99% | 16 |
|
|
2017
Q1 | $9.79M | Sell |
301,647
-15,590
| -5% | -$492K | 2.15% | 13 |
|
|
2016
Q4 | $9.78M | Sell |
317,237
-4,201
| -1% | -$128K | 2.35% | 9 |
|
|
2016
Q3 | $9.92M | Sell |
321,438
-316
| -0.1% | -$10.6K | 2.52% | 8 |
|
|
2016
Q2 | $10.7M | Sell |
321,754
-3,554
| -1% | -$113K | 2.88% | 6 |
|
|
2016
Q1 | $9.15M | Sell |
325,308
-145,291
| -31% | -$4.15M | 2.27% | 13 |
|
|
2015
Q4 | $14.4M | Sell |
470,599
-4,537
| -1% | -$143K | 3.43% | 2 |
|
|
2015
Q3 | $14.2M | Buy |
475,136
+18,048
| +4% | +$579K | 3.56% | 1 |
|
|
2015
Q2 | $14.5M | Sell |
457,088
-10,939
| -2% | -$357K | 3.56% | 1 |
|
|
2015
Q1 | $15.4M | Buy |
468,027
+54
| +0% | +$1.72K | 3.88% | 1 |
|
|
2014
Q4 | $13.8M | Buy |
467,973
+14,036
| +3% | +$402K | 3.76% | 1 |
|
|
2014
Q3 | $12.7M | Buy |
453,937
+3,861
| +0.9% | +$108K | 3.67% | 1 |
|
|
2014
Q2 | $12.7M | Buy |
450,076
+22,605
| +5% | +$644K | 3.87% | 1 |
|
|
2014
Q1 | $13M | Buy |
427,471
+1,399
| +0.3% | +$41.7K | 4.22% | 1 |
|
|
2013
Q4 | $12.4M | Sell |
426,072
-2,539
| -0.6% | -$73.9K | 4.09% | 2 |
|
|
2013
Q3 | $11.7M | Sell |
428,611
-753
| -0.2% | -$20.5K | 4.65% | 1 |
|
|
2013
Q2 | $11.4M | Buy |
+429,364
| New | +$11.9M | 5.12% | 1 |
|
Other funds holding PFE
AWA
Financial Partners Capital Management's PFE Position: Q4 2022 in Review
Financial Partners Capital Management increased its Pfizer (PFE) stake by 0.18% in Q4 2022, buying an estimated $22K and bringing the position to 254,633 shares worth $13M. The position accounts for 2.9% of the portfolio, ranked #9.
Financial Partners Capital Management first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $15.4M in Q1 2015. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Financial Partners Capital Management held 254,633 shares of Pfizer worth $13M as of Q4 2022.
- Financial Partners Capital Management bought 459 Pfizer shares in Q4 2022, an estimated $22K.
- Pfizer made up 2.9% of Financial Partners Capital Management's portfolio in Q4 2022, its #9 holding.
- Financial Partners Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- Financial Partners Capital Management's Pfizer position peaked at $15.4M in Q1 2015.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Financial Partners Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.